General MedicationsBUCCAL, SUBLINGUALGeneric

FENTANYL CITRATE

Standard Dose

EQ 0.3MG BASE

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview FENTANYL CITRATE is listed in Drugs@FDA under application 206329 (ANDA).

Marketing status: Discontinued Active ingredient FENTANYL CITRATE Form and strength TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE Sponsor DR REDDYS LABS SA Submission history Latest submission status date: 2022-12-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview FENTANYL CITRATE is listed in Drugs@FDA under application 206329 (ANDA). Marketing status: Discontinued Active ingredient FENTANYL CITRATE Form and strength TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE Sponsor DR REDDYS LABS SA Submission history Latest submission status date: 2022-12-08 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.